National Jewish Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:National Jewish Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014027
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmental and occupational health, gastroenterology, interstitial lung disease, nephrology, oncology, pulmonology, respiratory and others. It also offers educational services to physicians, scientists, healthcare professionals and others. The center operates in New York, California, Washington, D.C., Florida and Illinois. NJH is headquartered in Denver, Colorado, the US.

National Jewish Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Jewish Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Jewish Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
National Jewish Health, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
National Jewish Health, Saint Joseph’s Hospital and SCL Health Announce to Form Joint Venture 10
National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 11
Licensing Agreements 12
Aeolus Pharma Enters into Licensing Agreement with National Jewish Health 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 13
OrPro Therapeutics Enters into Licensing Agreement with National Jewish Health 14
National Jewish Health – Key Competitors 15
National Jewish Health – Key Employees 16
National Jewish Health – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
Nov 14, 2017: $8.5M Grant Awarded to Improve Asthma Care with the Navajo Nation 21
Aug 17, 2016: Acetaminophen Safe for Use in Children with Asthma 22
Jul 26, 2016: National Jewish Health Awarded $11.5 Million in Department of Defense Grants 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
National Jewish Health, Pharmaceuticals & Healthcare, Key Facts 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Jewish Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Jewish Health, Deals By Therapy Area, 2011 to YTD 2017 8
National Jewish Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
National Jewish Health, Saint Joseph's Hospital and SCL Health Announce to Form Joint Venture 10
National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 11
Aeolus Pharma Enters into Licensing Agreement with National Jewish Health 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 13
OrPro Therapeutics Enters into Licensing Agreement with National Jewish Health 14
National Jewish Health, Key Competitors 15
National Jewish Health, Key Employees 16
National Jewish Health, Key Employees (cont..) 18
National Jewish Health, Other Locations 19
National Jewish Health, Joint Venture 20

★海外企業調査レポート[National Jewish Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization’s service portfolio includes process development and cGMP manufacturing of reco …
  • China North Industries Corporation:企業の戦略・SWOT・財務情報
    China North Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary China North Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Guangzhou Institute of Biomedicine and Health-製薬・医療分野:企業M&A・提携分析
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that conducts research on stem cell and regenerative medicine, chemical biology, infection and immunity, public health and scientific research equipment development. The institute’s life process and disease mechanis …
  • King Country Energy Limited:企業の戦略的SWOT分析
    King Country Energy Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Shenzhen Moso Power Supply Technology Co Ltd (002660):電力:M&Aディール及び事業提携情報
    Summary Shenzhen Moso Power Supply Technology Co Ltd (Moso Power) is a manufacturer of electronics and electrical appliances. The company designs and distributes consumer electronics and solar photovoltaic products. Its products include LED driver, outdoor lighting, industrial lighting, landscape li …
  • Applied Genetic Technologies Corp (AGTC):製薬・医療:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • Amphastar Pharmaceuticals Inc (AMPH):企業の財務・戦略的SWOT分析
    Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Barrick Gold Corp:企業の戦略・SWOT・財務情報
    Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alfa SAB de CV (ALFAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa SAB de CV (Alfa) is a diversified company that operates in the petrochemical, refrigerated food, lightweight solutions, telecommunication, and oil and gas sectors. Alfa develops and manufactures high technology aluminum components for the power train and body structure of automotive. It …
  • VION N.V.:企業のM&A・事業提携・投資動向
    VION N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VION N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • SeQuent Scientific Ltd (512529):企業の財務・戦略的SWOT分析
    Summary SeQuent Scientific Ltd (SeQuent) is a pharmaceutical company that develops and manufactures animal health API, life science and industrial products. The company offers products such as aciclovir sodium, albendazole, artemether, artesunate, amyl meta cresol, citicoline sodium and dihydroartem …
  • CardioDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Telephonics Corp:企業の戦略的SWOT分析
    Telephonics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Kia Motors Corporation (000270):企業の財務・戦略的SWOT分析
    Kia Motors Corporation (000270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sunrise Senior Living LLC:企業の戦略・SWOT・財務情報
    Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Yamana Gold Inc.:企業のM&A・事業提携・投資動向
    Yamana Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yamana Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • JSC Insurance Company Aldagi:企業の戦略・SWOT・財務情報
    JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report Summary JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆